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Background
Hypertension (HTN) is a major worldwide cause of
stroke, heart failure, myocardial infarction, and chronic
kidney disease. Mechanisms of blood pressure regulation
have previously been elucidated from the study of animal
models, Mendelian hyper- and hypo-tension in humans,
and drug treatment trials. More recently, genome-wide
association studies (GWASs) have offered unbiased
approaches to identify novel mechanisms contributing to
blood pressure control. We and others have reported
candidate gene and GWASs that have identified common
genetic variants of modest effect on blood pressure that
fall in pathways involving natriuretic peptide and nitric
oxide signalling [1-3].
Results
Common variant rs5068 in the 3’ UTR of NPPA, which
encodes the atrial natriuretic peptide (ANP), is associated
with higher plasma ANP and lower blood pressure and
odds of hypertension [2]. We have now completed a geno-
type-directed physiologic study of 8 heterozygotes and
23 major homozygotes demonstrating that the variant
alters the “set point” of ANP (p=0.02) but does not alter
the ANP response to high vs low sodium diet (p<0.0001)
or to intravenous saline infusion (p<0.0001, in press); addi-
tional evidence for the mechanism by which this variant
acts will be presented in a separate abstract. Downstream
of the natriuretic peptide system, a common noncoding
variant at a locus including NPR3, encoding the natriuretic
peptide clearance receptor, has been associated with blood
pressure although it is not associated with plasma ANP or
BNP [3]. A common variant at the locus including ENOS,
encoding endothelial nitric oxide synthase, is associated
with blood pressure and hypertension [4,5]. Lastly, an
intronic variant in GUCY1A3, encoding the alpha subunit
of soluble guanylate cyclase, is associated with blood pres-
sure and myocardial infarction risk.
Conclusion
The natriuretic peptide and nitric oxide systems are
important contributors to blood pressure regulation in
humans and represent strong targets for pharmacologic
intervention to reduce the burden of disease from
hypertension.
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